 | • レポートコード：MRC2-11QY03139 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は過食症治療薬のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、抗けいれん薬、抗肥満薬）市場規模、用途別（小売薬局、病院薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別過食症治療薬の競争状況、市場シェア ・世界の過食症治療薬市場：種類別市場規模 2015年-2020年（抗うつ薬、抗けいれん薬、抗肥満薬） ・世界の過食症治療薬市場：種類別市場規模予測 2021年-2026年（抗うつ薬、抗けいれん薬、抗肥満薬） ・世界の過食症治療薬市場：用途別市場規模 2015年-2020年（小売薬局、病院薬局、オンライン薬局） ・世界の過食症治療薬市場：用途別市場規模予測 2021年-2026年（小売薬局、病院薬局、オンライン薬局） ・北米の過食症治療薬市場分析：米国、カナダ ・ヨーロッパの過食症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの過食症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の過食症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの過食症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Chronos Therapeutics、Heptares、Novo Nordisk、Omeros Corp、Sunovion Pharmaceuticals、Opiant Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychotherapy, medications and behavioral weight-loss programs.
Market Analysis and Insights: Global Binge Eating Disorder Drug Market
The global Binge Eating Disorder Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Binge Eating Disorder Drug Scope and Market Size
Binge Eating Disorder Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Binge Eating Disorder Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Binge Eating Disorder Drug market is segmented into
Antidepressants
Anticonvulsants
Anti-obesity Medications
Segment by Application, the Binge Eating Disorder Drug market is segmented into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Binge Eating Disorder Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Binge Eating Disorder Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Binge Eating Disorder Drug Market Share Analysis
Binge Eating Disorder Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Binge Eating Disorder Drug business, the date to enter into the Binge Eating Disorder Drug market, Binge Eating Disorder Drug product introduction, recent developments, etc.
The major vendors covered:
Roche
Chronos Therapeutics
Heptares
Novo Nordisk
Omeros Corp
Sunovion Pharmaceuticals
Opiant Pharmaceuticals
…
1 Study Coverage
1.1 Binge Eating Disorder Drug Product Introduction
1.2 Market Segments
1.3 Key Binge Eating Disorder Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Binge Eating Disorder Drug Market Size Growth Rate by Type
1.4.2 Antidepressants
1.4.3 Anticonvulsants
1.4.4 Anti-obesity Medications
1.5 Market by Application
1.5.1 Global Binge Eating Disorder Drug Market Size Growth Rate by Application
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Binge Eating Disorder Drug Market Size, Estimates and Forecasts
2.1.1 Global Binge Eating Disorder Drug Revenue 2015-2026
2.1.2 Global Binge Eating Disorder Drug Sales 2015-2026
2.2 Global Binge Eating Disorder Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Binge Eating Disorder Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Binge Eating Disorder Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Binge Eating Disorder Drug Competitor Landscape by Players
3.1 Binge Eating Disorder Drug Sales by Manufacturers
3.1.1 Binge Eating Disorder Drug Sales by Manufacturers (2015-2020)
3.1.2 Binge Eating Disorder Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Binge Eating Disorder Drug Revenue by Manufacturers
3.2.1 Binge Eating Disorder Drug Revenue by Manufacturers (2015-2020)
3.2.2 Binge Eating Disorder Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Binge Eating Disorder Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Binge Eating Disorder Drug Revenue in 2019
3.2.5 Global Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Binge Eating Disorder Drug Price by Manufacturers
3.4 Binge Eating Disorder Drug Manufacturing Base Distribution, Product Types
3.4.1 Binge Eating Disorder Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Binge Eating Disorder Drug Product Type
3.4.3 Date of International Manufacturers Enter into Binge Eating Disorder Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Binge Eating Disorder Drug Market Size by Type (2015-2020)
4.1.1 Global Binge Eating Disorder Drug Sales by Type (2015-2020)
4.1.2 Global Binge Eating Disorder Drug Revenue by Type (2015-2020)
4.1.3 Binge Eating Disorder Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Binge Eating Disorder Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Binge Eating Disorder Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Binge Eating Disorder Drug Revenue Forecast by Type (2021-2026)
4.2.3 Binge Eating Disorder Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Binge Eating Disorder Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Binge Eating Disorder Drug Market Size by Application (2015-2020)
5.1.1 Global Binge Eating Disorder Drug Sales by Application (2015-2020)
5.1.2 Global Binge Eating Disorder Drug Revenue by Application (2015-2020)
5.1.3 Binge Eating Disorder Drug Price by Application (2015-2020)
5.2 Binge Eating Disorder Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Binge Eating Disorder Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Binge Eating Disorder Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Binge Eating Disorder Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Binge Eating Disorder Drug by Country
6.1.1 North America Binge Eating Disorder Drug Sales by Country
6.1.2 North America Binge Eating Disorder Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Binge Eating Disorder Drug Market Facts & Figures by Type
6.3 North America Binge Eating Disorder Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Binge Eating Disorder Drug by Country
7.1.1 Europe Binge Eating Disorder Drug Sales by Country
7.1.2 Europe Binge Eating Disorder Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Binge Eating Disorder Drug Market Facts & Figures by Type
7.3 Europe Binge Eating Disorder Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Binge Eating Disorder Drug by Region
8.1.1 Asia Pacific Binge Eating Disorder Drug Sales by Region
8.1.2 Asia Pacific Binge Eating Disorder Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Binge Eating Disorder Drug Market Facts & Figures by Type
8.3 Asia Pacific Binge Eating Disorder Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Binge Eating Disorder Drug by Country
9.1.1 Latin America Binge Eating Disorder Drug Sales by Country
9.1.2 Latin America Binge Eating Disorder Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Binge Eating Disorder Drug Market Facts & Figures by Type
9.3 Central & South America Binge Eating Disorder Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Binge Eating Disorder Drug by Country
10.1.1 Middle East and Africa Binge Eating Disorder Drug Sales by Country
10.1.2 Middle East and Africa Binge Eating Disorder Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Binge Eating Disorder Drug Market Facts & Figures by Type
10.3 Middle East and Africa Binge Eating Disorder Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Binge Eating Disorder Drug Products Offered
11.1.5 Roche Related Developments
11.2 Chronos Therapeutics
11.2.1 Chronos Therapeutics Corporation Information
11.2.2 Chronos Therapeutics Description and Business Overview
11.2.3 Chronos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Chronos Therapeutics Binge Eating Disorder Drug Products Offered
11.2.5 Chronos Therapeutics Related Developments
11.3 Heptares
11.3.1 Heptares Corporation Information
11.3.2 Heptares Description and Business Overview
11.3.3 Heptares Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Heptares Binge Eating Disorder Drug Products Offered
11.3.5 Heptares Related Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Corporation Information
11.4.2 Novo Nordisk Description and Business Overview
11.4.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novo Nordisk Binge Eating Disorder Drug Products Offered
11.4.5 Novo Nordisk Related Developments
11.5 Omeros Corp
11.5.1 Omeros Corp Corporation Information
11.5.2 Omeros Corp Description and Business Overview
11.5.3 Omeros Corp Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Omeros Corp Binge Eating Disorder Drug Products Offered
11.5.5 Omeros Corp Related Developments
11.6 Sunovion Pharmaceuticals
11.6.1 Sunovion Pharmaceuticals Corporation Information
11.6.2 Sunovion Pharmaceuticals Description and Business Overview
11.6.3 Sunovion Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sunovion Pharmaceuticals Binge Eating Disorder Drug Products Offered
11.6.5 Sunovion Pharmaceuticals Related Developments
11.7 Opiant Pharmaceuticals
11.7.1 Opiant Pharmaceuticals Corporation Information
11.7.2 Opiant Pharmaceuticals Description and Business Overview
11.7.3 Opiant Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Opiant Pharmaceuticals Binge Eating Disorder Drug Products Offered
11.7.5 Opiant Pharmaceuticals Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Binge Eating Disorder Drug Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Binge Eating Disorder Drug Market Estimates and Projections by Region
12.1.1 Global Binge Eating Disorder Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Binge Eating Disorder Drug Revenue Forecast by Regions 2021-2026
12.2 North America Binge Eating Disorder Drug Market Size Forecast (2021-2026)
12.2.1 North America: Binge Eating Disorder Drug Sales Forecast (2021-2026)
12.2.2 North America: Binge Eating Disorder Drug Revenue Forecast (2021-2026)
12.2.3 North America: Binge Eating Disorder Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Binge Eating Disorder Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Binge Eating Disorder Drug Sales Forecast (2021-2026)
12.3.2 Europe: Binge Eating Disorder Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Binge Eating Disorder Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Binge Eating Disorder Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Binge Eating Disorder Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Binge Eating Disorder Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Binge Eating Disorder Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Binge Eating Disorder Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Binge Eating Disorder Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Binge Eating Disorder Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Binge Eating Disorder Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Binge Eating Disorder Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Binge Eating Disorder Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Binge Eating Disorder Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Binge Eating Disorder Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Binge Eating Disorder Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Binge Eating Disorder Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Binge Eating Disorder Drug Market Segments
Table 2. Ranking of Global Top Binge Eating Disorder Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Binge Eating Disorder Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Antidepressants
Table 5. Major Manufacturers of Anticonvulsants
Table 6. Major Manufacturers of Anti-obesity Medications
Table 7. Global Binge Eating Disorder Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Binge Eating Disorder Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Binge Eating Disorder Drug Sales by Regions 2015-2020 (K MT)
Table 10. Global Binge Eating Disorder Drug Sales Market Share by Regions (2015-2020)
Table 11. Global Binge Eating Disorder Drug Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Binge Eating Disorder Drug Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Binge Eating Disorder Drug Sales Share by Manufacturers (2015-2020)
Table 14. Global Binge Eating Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Binge Eating Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Binge Eating Disorder Drug as of 2019)
Table 16. Binge Eating Disorder Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Binge Eating Disorder Drug Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Binge Eating Disorder Drug Price (2015-2020) (USD/MT)
Table 19. Binge Eating Disorder Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Binge Eating Disorder Drug Product Type
Table 21. Date of International Manufacturers Enter into Binge Eating Disorder Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Binge Eating Disorder Drug Sales by Type (2015-2020) (K MT)
Table 24. Global Binge Eating Disorder Drug Sales Share by Type (2015-2020)
Table 25. Global Binge Eating Disorder Drug Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Binge Eating Disorder Drug Revenue Share by Type (2015-2020)
Table 27. Binge Eating Disorder Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Binge Eating Disorder Drug Sales by Application (2015-2020) (K MT)
Table 29. Global Binge Eating Disorder Drug Sales Share by Application (2015-2020)
Table 30. North America Binge Eating Disorder Drug Sales by Country (2015-2020) (K MT)
Table 31. North America Binge Eating Disorder Drug Sales Market Share by Country (2015-2020)
Table 32. North America Binge Eating Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Binge Eating Disorder Drug Revenue Market Share by Country (2015-2020)
Table 34. North America Binge Eating Disorder Drug Sales by Type (2015-2020) (K MT)
Table 35. North America Binge Eating Disorder Drug Sales Market Share by Type (2015-2020)
Table 36. North America Binge Eating Disorder Drug Sales by Application (2015-2020) (K MT)
Table 37. North America Binge Eating Disorder Drug Sales Market Share by Application (2015-2020)
Table 38. Europe Binge Eating Disorder Drug Sales by Country (2015-2020) (K MT)
Table 39. Europe Binge Eating Disorder Drug Sales Market Share by Country (2015-2020)
Table 40. Europe Binge Eating Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Binge Eating Disorder Drug Revenue Market Share by Country (2015-2020)
Table 42. Europe Binge Eating Disorder Drug Sales by Type (2015-2020) (K MT)
Table 43. Europe Binge Eating Disorder Drug Sales Market Share by Type (2015-2020)
Table 44. Europe Binge Eating Disorder Drug Sales by Application (2015-2020) (K MT)
Table 45. Europe Binge Eating Disorder Drug Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Binge Eating Disorder Drug Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Binge Eating Disorder Drug Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Binge Eating Disorder Drug Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Binge Eating Disorder Drug Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Binge Eating Disorder Drug Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Binge Eating Disorder Drug Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Binge Eating Disorder Drug Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Binge Eating Disorder Drug Sales Market Share by Application (2015-2020)
Table 54. Latin America Binge Eating Disorder Drug Sales by Country (2015-2020) (K MT)
Table 55. Latin America Binge Eating Disorder Drug Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Binge Eating Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Binge Eating Disorder Drug Revenue Market Share by Country (2015-2020)
Table 58. Latin America Binge Eating Disorder Drug Sales by Type (2015-2020) (K MT)
Table 59. Latin America Binge Eating Disorder Drug Sales Market Share by Type (2015-2020)
Table 60. Latin America Binge Eating Disorder Drug Sales by Application (2015-2020) (K MT)
Table 61. Latin America Binge Eating Disorder Drug Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Binge Eating Disorder Drug Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Binge Eating Disorder Drug Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Binge Eating Disorder Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Binge Eating Disorder Drug Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Binge Eating Disorder Drug Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Binge Eating Disorder Drug Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Binge Eating Disorder Drug Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Binge Eating Disorder Drug Sales Market Share by Application (2015-2020)
Table 70. Roche Corporation Information
Table 71. Roche Description and Major Businesses
Table 72. Roche Binge Eating Disorder Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Roche Product
Table 74. Roche Recent Development
Table 75. Chronos Therapeutics Corporation Information
Table 76. Chronos Therapeutics Description and Major Businesses
Table 77. Chronos Therapeutics Binge Eating Disorder Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Chronos Therapeutics Product
Table 79. Chronos Therapeutics Recent Development
Table 80. Heptares Corporation Information
Table 81. Heptares Description and Major Businesses
Table 82. Heptares Binge Eating Disorder Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Heptares Product
Table 84. Heptares Recent Development
Table 85. Novo Nordisk Corporation Information
Table 86. Novo Nordisk Description and Major Businesses
Table 87. Novo Nordisk Binge Eating Disorder Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Novo Nordisk Product
Table 89. Novo Nordisk Recent Development
Table 90. Omeros Corp Corporation Information
Table 91. Omeros Corp Description and Major Businesses
Table 92. Omeros Corp Binge Eating Disorder Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Omeros Corp Product
Table 94. Omeros Corp Recent Development
Table 95. Sunovion Pharmaceuticals Corporation Information
Table 96. Sunovion Pharmaceuticals Description and Major Businesses
Table 97. Sunovion Pharmaceuticals Binge Eating Disorder Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Sunovion Pharmaceuticals Product
Table 99. Sunovion Pharmaceuticals Recent Development
Table 100. Opiant Pharmaceuticals Corporation Information
Table 101. Opiant Pharmaceuticals Description and Major Businesses
Table 102. Opiant Pharmaceuticals Binge Eating Disorder Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Opiant Pharmaceuticals Product
Table 104. Opiant Pharmaceuticals Recent Development
Table 105. Global Binge Eating Disorder Drug Sales Forecast by Regions (2021-2026) (K MT)
Table 106. Global Binge Eating Disorder Drug Sales Market Share Forecast by Regions (2021-2026)
Table 107. Global Binge Eating Disorder Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 108. Global Binge Eating Disorder Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 109. North America: Binge Eating Disorder Drug Sales Forecast by Country (2021-2026) (K MT)
Table 110. North America: Binge Eating Disorder Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Europe: Binge Eating Disorder Drug Sales Forecast by Country (2021-2026) (K MT)
Table 112. Europe: Binge Eating Disorder Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Asia Pacific: Binge Eating Disorder Drug Sales Forecast by Region (2021-2026) (K MT)
Table 114. Asia Pacific: Binge Eating Disorder Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 115. Latin America: Binge Eating Disorder Drug Sales Forecast by Country (2021-2026) (K MT)
Table 116. Latin America: Binge Eating Disorder Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Middle East and Africa: Binge Eating Disorder Drug Sales Forecast by Country (2021-2026) (K MT)
Table 118. Middle East and Africa: Binge Eating Disorder Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Binge Eating Disorder Drug Players
Table 123. Binge Eating Disorder Drug Customers List
Table 124. Binge Eating Disorder Drug Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Binge Eating Disorder Drug Product Picture
Figure 2. Global Binge Eating Disorder Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Antidepressants Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Anti-obesity Medications Product Picture
Figure 6. Global Binge Eating Disorder Drug Sales Market Share by Application in 2020 & 2026
Figure 7. Retail Pharmacies
Figure 8. Hospital Pharmacies
Figure 9. Online Pharmacies
Figure 10. Binge Eating Disorder Drug Report Years Considered
Figure 11. Global Binge Eating Disorder Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Binge Eating Disorder Drug Sales 2015-2026 (K MT)
Figure 13. Global Binge Eating Disorder Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Binge Eating Disorder Drug Sales Market Share by Region (2015-2020)
Figure 15. Global Binge Eating Disorder Drug Sales Market Share by Region in 2019
Figure 16. Global Binge Eating Disorder Drug Revenue Market Share by Region (2015-2020)
Figure 17. Global Binge Eating Disorder Drug Revenue Market Share by Region in 2019
Figure 18. Global Binge Eating Disorder Drug Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Binge Eating Disorder Drug Revenue in 2019
Figure 20. Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Binge Eating Disorder Drug Sales Market Share by Type (2015-2020)
Figure 22. Global Binge Eating Disorder Drug Sales Market Share by Type in 2019
Figure 23. Global Binge Eating Disorder Drug Revenue Market Share by Type (2015-2020)
Figure 24. Global Binge Eating Disorder Drug Revenue Market Share by Type in 2019
Figure 25. Global Binge Eating Disorder Drug Market Share by Price Range (2015-2020)
Figure 26. Global Binge Eating Disorder Drug Sales Market Share by Application (2015-2020)
Figure 27. Global Binge Eating Disorder Drug Sales Market Share by Application in 2019
Figure 28. Global Binge Eating Disorder Drug Revenue Market Share by Application (2015-2020)
Figure 29. Global Binge Eating Disorder Drug Revenue Market Share by Application in 2019
Figure 30. North America Binge Eating Disorder Drug Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Binge Eating Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Binge Eating Disorder Drug Sales Market Share by Country in 2019
Figure 33. North America Binge Eating Disorder Drug Revenue Market Share by Country in 2019
Figure 34. U.S. Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Binge Eating Disorder Drug Market Share by Type in 2019
Figure 39. North America Binge Eating Disorder Drug Market Share by Application in 2019
Figure 40. Europe Binge Eating Disorder Drug Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Binge Eating Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Binge Eating Disorder Drug Sales Market Share by Country in 2019
Figure 43. Europe Binge Eating Disorder Drug Revenue Market Share by Country in 2019
Figure 44. Germany Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Binge Eating Disorder Drug Market Share by Type in 2019
Figure 55. Europe Binge Eating Disorder Drug Market Share by Application in 2019
Figure 56. Asia Pacific Binge Eating Disorder Drug Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Binge Eating Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Binge Eating Disorder Drug Sales Market Share by Region in 2019
Figure 59. Asia Pacific Binge Eating Disorder Drug Revenue Market Share by Region in 2019
Figure 60. China Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Binge Eating Disorder Drug Market Share by Type in 2019
Figure 83. Asia Pacific Binge Eating Disorder Drug Market Share by Application in 2019
Figure 84. Latin America Binge Eating Disorder Drug Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Binge Eating Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Binge Eating Disorder Drug Sales Market Share by Country in 2019
Figure 87. Latin America Binge Eating Disorder Drug Revenue Market Share by Country in 2019
Figure 88. Mexico Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Binge Eating Disorder Drug Market Share by Type in 2019
Figure 95. Latin America Binge Eating Disorder Drug Market Share by Application in 2019
Figure 96. Middle East and Africa Binge Eating Disorder Drug Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Binge Eating Disorder Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Binge Eating Disorder Drug Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Binge Eating Disorder Drug Revenue Market Share by Country in 2019
Figure 100. Turkey Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Binge Eating Disorder Drug Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Binge Eating Disorder Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Binge Eating Disorder Drug Market Share by Type in 2019
Figure 107. Middle East and Africa Binge Eating Disorder Drug Market Share by Application in 2019
Figure 108. North America Binge Eating Disorder Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Binge Eating Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Binge Eating Disorder Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Binge Eating Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Binge Eating Disorder Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Binge Eating Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Binge Eating Disorder Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Binge Eating Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Binge Eating Disorder Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Binge Eating Disorder Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…- 胃運動障害治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gastric Motility Disorder Drug Market The global Gastric Motility Disorder Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastric Motility Disorder Drug Scope and Market Size …
- 胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年） Fetal alcohol spectrum disorder are the group of conditions occurring in new born with a wide range of disabilities. Fetal alcohol spectrum disorder treatment market is an evolving market owing to the gradual change in the lifestyle and increased alcohol consumption by pregnant women, eventually inc…
- 睡眠障害治療薬の世界市場（～2026年） Sleep disorders result in a lack of deep and restorative sleep. The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global Sleep Disorder Therapeutics …
- 双極性障害治療の世界市場（～2026年） Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. Accord…